Research Article

Experimental and Clinical Applications of Chamaecyparis obtusa Extracts in Dry Eye Disease

Figure 4

Mean tear volumes (a), tear film break-up time (b), corneal fluorescein staining scores (c), and representative figures (d) of the untreated (UT) control, experimental dry eye (EDE), balanced salt solution (BSS), and 0.001%, 0.01%, and 0.1% Chamaecyparis obtusa (CO) extract groups 7 days after desiccant stress. compared with the EDE group. compared with the BSS group. compared with the 0.001% CO extract group. compared with the 0.01% CO extract group. compared with the 0.1% CO extract group.
(a)
(b)
(c)
(d)